To test whether IFN-γ was activated in the administration of ferroptosis of NSCLC cells, the ferroptosis specific inhibitor ferrostatin-1 (Fer-1) was utilized to treated NSCLC cells. The gene discussed is IFNG; the disease is non-small cell lung carcinoma.